James M. Thorburn, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 12,442 shares at $90.51 ($1.1M) on 2021-12-08, disclosed to the SEC on 2021-12-10.
Open-market sale of $1.1M TWST by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.34 | 200 | $17K | 1.5% |
| 2 | $85.72 | 267 | $23K | 2.1% |
| 3 | $87.08 | 600 | $52K | 4.7% |
| 4 | $88.37 | 831 | $73K | 6.6% |
| 5 | $88.37 | 831 | $73K | 6.6% |
| 6 | $89.73 | 2,399 |
| $215K |
| 19.3% |
| 7 | $89.73 | 2,399 | $215K | 19.3% |
| 8 | $90.51 | 2,212 | $200K | 18.0% |
| 9 | $90.51 | 2,212 | $200K | 18.0% |
| 10 | $91.35 | 491 | $45K | 4.0% |
| Total | $89.57 avg | 12,442 | $1.1M | 100% |
| Filing → |
| TWST | SELL | 2022-04-18 | $518K | — | Filing → |
| TWST | SELL | 2022-03-07 | $359K | — | Filing → |
| TWST | SELL | 2022-02-23 | $432K | — | Filing → |